A certificate of analysis (COA) is a report about specified tests on an identified sample. Its value depends on traceability, method suitability, units, acceptance criteria, and honest limits. It is not a universal certificate of supplier quality, sterility, clinical safety, or effectiveness.
Read the document in this order
- Match the object: product or sample name, batch or lot, report number, dates, and laboratory identity.
- Identify the question: identity, assay, related substances, water, residual solvent, endotoxin, sterility, or another attribute.
- Inspect the method: named technique, sample preparation, reference standard, units, reportable range, and method version.
- Read the result against a criterion: a number without a predefined specification is not a pass.
- Check the limit: what sample was not tested, what the method cannot distinguish, and whether chain of custody is documented.
Claim, evidence, and limit
| COA element | What it may support | What it cannot establish by itself |
|---|---|---|
| Chromatographic purity | Relative signal distribution under stated separation and detection conditions. | Identity, total mass balance, sterility, endotoxin, or absence of every impurity. |
| Mass spectrometry | Mass information consistent with a proposed molecule or fragment. | Complete sequence, purity, biological activity, or clinical suitability without additional method context. |
| Assay or content | Amount measured by a suitable procedure against a reference. | That all units in a batch are uniform or remained stable after later storage and shipping. |
| Endotoxin result | Result for bacterial endotoxins under the reported method, units, dilution, and sample conditions. | Sterility, absence of non-endotoxin pyrogens, or safety for a person. |
| Third-party laboratory name | Who issued the report, if independently verifiable. | That the laboratory selected the sample or that the sample represents every lot. |
Identity and purity are different analytical questions
The ICH Q2(R2) guideline treats identity, assay or potency, purity, impurities, and other measurements as distinct intended uses for analytical procedures. A method should be validated or qualified for the question it answers. Combining two methods can strengthen a conclusion when they are genuinely orthogonal, but two weak or mismatched methods do not become one strong result.
FDA’s Q6A guidance likewise separates identity, assay, impurities, and microbiological attributes within a specification. That is why “99% purity” cannot substitute for a complete specification.
Endotoxin is not sterility
An endotoxin statement needs a method, units and denominator, dilution or sample preparation, acceptance limit, and evidence that the product did not interfere with the test. FDA’s pyrogen and endotoxin testing guidance discusses method suitability and the relationship to compendial bacterial-endotoxin testing. Sterility is a separate microbiological attribute. Neither result establishes clinical benefit.
Compact red-flag checklist
- No lot or report identifier that connects the document to the sample.
- Results without methods, units, acceptance criteria, or test dates.
- A purity percentage presented as proof of identity, sterility, or safety.
- An endotoxin claim without units, denominator, method, or suitability information.
- A cropped image, editable template, or laboratory name that cannot be independently confirmed.
- One favorable result generalized to other lots, later handling, or human use.
Bottom line: a COA can be useful when it is sample-bound, method-specific, and traceable. Read it as a set of limited analytical statements—not as a verdict on a vendor or a substitute for clinical and regulatory evidence.
